Coherus BioSciences Company Insiders

Coherus BioSciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.1403) % which means that it has lost $0.1403 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (16.5706) %, meaning that it created substantial loss on money invested by shareholders. Coherus BioSciences' management efficiency ratios could be used to measure how well Coherus BioSciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 1.97 in 2025, whereas Return On Tangible Assets are likely to drop (0.40) in 2025. At this time, Coherus BioSciences' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 86.1 M in 2025, whereas Total Current Assets are likely to drop slightly above 311.1 M in 2025. Common Stock Shares Outstanding is likely to drop to about 54.8 M in 2025. Net Loss is likely to gain to about (249.4 M) in 2025

Coherus BioSciences Workforce Comparison

Coherus BioSciences Insider Trading

Coherus BioSciences Notable Stakeholders

The success or failure of an entity such as Coherus BioSciences often depends on how effective the management is. Coherus BioSciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Coherus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Coherus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Coherus BioSciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Coherus BioSciences. Check Coherus BioSciences' Beneish M Score to see the likelihood of Coherus BioSciences' management manipulating its earnings.

When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.